Forbes J M & CO LLP Nuvectis Pharma, Inc. Transaction History
Forbes J M & CO LLP
- $1 Billion
- Q1 2025
A detailed history of Forbes J M & CO LLP transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 59,000 shares of NVCT stock, worth $609,470. This represents 0.06% of its overall portfolio holdings.
Number of Shares
59,000
Previous 59,000
-0.0%
Holding current value
$609,470
Previous $320,000
80.0%
% of portfolio
0.06%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding NVCT
# of Institutions
33Shares Held
2.23MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$5.81 Million5.37% of portfolio
-
Baldwin Brothers LLC358KShares$3.7 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$3.36 Million0.0% of portfolio
-
Iridian Asset Management LLC254KShares$2.62 Million0.82% of portfolio
-
Marshall Wace, LLP London, X0125KShares$1.29 Million0.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $151M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...